May 30, 2018

Ambien Hits Back at Roseanne: “Racism Is Not a Known Side Effect”

The just-fired TV host had blamed her sleeping pills for a bigoted tweet.

Kristin Callahan/ZUMA

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.

The manufacturer of Ambien is pushing back against Roseanne Barr’s attempt to blame the drug for a racist tweet she published and deleted Tuesday. 

“People of all races, religions and nationalities work at Sanofi every day to improve the lives of people around the world,” Sanofi US, the company behind the commonly prescribed sleeping pill, said in a Wednesday statement. “While all pharmaceutical treatments have side effects, racism is not a known side effect of any Sanofi medication.”

The company was responding to another since deleted tweet Barr sent on Wednesday, where the TV star claimed “ambien tweeting” prompted her to liken Valerie Jarrett, a former senior adviser to Barack Obama who is black, to an ape. Just hours after that tweet gained attention on social media, ABC said it was canceling Roseanne for what it denounced as an “abhorrent” and “repugnant” statement by Barr.

The 2018 reboot of the popular sitcom had been attracting high ratings—even while some jokes drew controversy and as Barr kept up her well-established record of promoting baseless, right-wing conspiracy theories.

Despite Barr’s announcement that she would soon be leaving Twitter, along with a public apology she sent to Jarrett, Barr continued to retweet right-wing conspiracy theories about the former Obama adviser well into Wednesday evening. Other Barr retweets suggested ABC was wrong to cancel Roseanne and that Barr thought the company had applied a double standard in choosing to dismiss her.

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate